ARKG vs SCHH

ARK Genomic Revolution ETF vs Schwab US REIT ETF

Quick take
  • SCHH has the lower expense ratio at 0.07% vs 0.75% for ARKG.
  • SCHH pays a higher dividend yield (2.78%).

Side-by-side metrics

MetricARKGSCHH
Expense ratio
Annual fee. Lower is better.
0.75%0.07%
Dividend yield
Trailing 12-month yield.
0.00%2.78%
AUM
Assets under management — bigger funds are typically more liquid.
$1.24B$9.93B
YTD return
7.21%13.68%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.351.05
P/E ratio
30.73
Last price
$30.38$23.44
Inception
Issuer
ARKSchwab

ARKG top holdings

Top holdings · ARKG
TEMTempus AI Inc Class A common stock9.45%
TWSTTwist Bioscience Corp9.02%
CRSPCRISPR Therapeutics AG8.94%
TXG10x Genomics Inc Ordinary Shares - Class A5.78%
BEAMBeam Therapeutics Inc5.44%
ABSIAbsci Corp4.79%
NTRANatera Inc4.08%
ILMNIllumina Inc4.04%
NTLAIntellia Therapeutics Inc3.83%
PSNLPersonalis Inc3.59%
Sector breakdown · ARKG
Healthcare100.0%

SCHH top holdings

Top holdings · SCHH
WELLWelltower Inc10.09%
PLDPrologis Inc8.80%
EQIXEquinix Inc5.06%
DLRDigital Realty Trust Inc4.52%
SPGSimon Property Group Inc4.43%
AMTAmerican Tower Corp4.20%
ORealty Income Corp4.19%
PSAPublic Storage3.34%
VTRVentas Inc2.99%
CCICrown Castle Inc2.69%
Sector breakdown · SCHH
Real Estate100.0%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About SCHH

SCHH (Schwab US REIT ETF) is US REITs at very low cost. Managed by Schwab, the fund carries $9.9B in assets under management, an expense ratio of 0.07%, a dividend yield of 2.78%. Its largest holding is Welltower Inc (WELL), which represents 10.1% of the portfolio. Real Estate is the fund's largest sector exposure at 100.0%.